标题
A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma
作者
关键词
-
出版物
Nature Reviews Endocrinology
Volume 12, Issue 4, Pages 192-202
出版商
Springer Nature
发表日期
2016-02-12
DOI
10.1038/nrendo.2016.11
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Tumor Genotype Determines Phenotype and Disease-related Outcomes in Thyroid Cancer
- (2015) Linwah Yip et al. ANNALS OF SURGERY
- Defining “mutation” and “polymorphism” in the era of personal genomics
- (2015) Roshan Karki et al. BMC Medical Genomics
- RASproto-oncogene in medullary thyroid carcinoma
- (2015) Margarida M Moura et al. ENDOCRINE-RELATED CANCER
- THERAPY OF ENDOCRINE DISEASE: Response and toxicity of small-molecule tyrosine kinase inhibitors in patients with thyroid carcinoma: a systematic review and meta-analysis
- (2015) E. N. Klein Hesselink et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- RET Fusion as a Novel Driver of Medullary Thyroid Carcinoma
- (2015) Elizabeth G. Grubbs et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
- (2015) Martin Schlumberger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Relevance ofBRAFV600EMutation Testing VersusRASPoint Mutations andRET/PTCRearrangements Evaluation in the Diagnosis of Thyroid Cancer
- (2015) Martina Rossi et al. THYROID
- Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
- (2015) Samuel A. Wells et al. THYROID
- Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology
- (2015) Yuri E. Nikiforov et al. THYROID
- Identification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid Cancer
- (2015) Jun Ho Ji et al. PLoS Genetics
- Integrated Genomic Characterization of Papillary Thyroid Carcinoma
- (2014) Nishant Agrawal et al. CELL
- Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma
- (2014) T. Nakaoku et al. CLINICAL CANCER RESEARCH
- Twenty years of lesson learning: how does theRETgenetic screening test impact the clinical management of medullary thyroid cancer?
- (2014) Cristina Romei et al. CLINICAL ENDOCRINOLOGY
- Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility
- (2014) Rodrigo A Toledo et al. ENDOCRINE-RELATED CANCER
- A Single-Tube Multiplexed Assay for Detecting ALK, ROS1, and RET Fusions in Lung Cancer
- (2014) Maruja E. Lira et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
- (2014) Marcia S Brose et al. LANCET
- High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas
- (2014) Michele Simbolo et al. VIRCHOWS ARCHIV
- Is there really an increased incidence of thyroid cancer?
- (2014) Juan P. Brito et al. Current Opinion in Endocrinology Diabetes and Obesity
- RET Recognition of GDNF-GFRα1 Ligand by a Composite Binding Site Promotes Membrane-Proximal Self-Association
- (2014) Kerry M. Goodman et al. Cell Reports
- The clinical spectrum of RET proto-oncogene mutations in codon 790
- (2013) Hélène Bihan et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Multiple Endocrine Neoplasia Type 2 and Familial Medullary Thyroid Carcinoma: An Update
- (2013) Samuel A. Wells et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers
- (2013) Julio C. Ricarte-Filho et al. JOURNAL OF CLINICAL INVESTIGATION
- Cabozantinib in Progressive Medullary Thyroid Cancer
- (2013) Rossella Elisei et al. JOURNAL OF CLINICAL ONCOLOGY
- Functional characterization of a novel FGFR1OP-RET rearrangement in hematopoietic malignancies
- (2013) Daniela Bossi et al. Molecular Oncology
- Response to Cabozantinib in Patients with RET Fusion-Positive Lung Adenocarcinomas
- (2013) Alexander Drilon et al. Cancer Discovery
- Frequency of close positioning of chromosomal loci detected by FRET correlates with their participation in carcinogenic rearrangements in human cells
- (2012) Manoj Gandhi et al. GENES CHROMOSOMES & CANCER
- Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years
- (2012) Cristina Romei et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- RETFusions Define a Unique Molecular and Clinicopathologic Subtype of Non–Small-Cell Lung Cancer
- (2012) Rui Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial
- (2012) Sophie Leboulleux et al. LANCET ONCOLOGY
- RET fusion genes are associated with chronic myelomonocytic leukemia and enhance monocytic differentiation
- (2012) P Ballerini et al. LEUKEMIA
- Alternative splicing results in RET isoforms with distinct trafficking properties
- (2012) Douglas S. Richardson et al. MOLECULAR BIOLOGY OF THE CELL
- KIF5B-RET fusions in lung adenocarcinoma
- (2012) Takashi Kohno et al. NATURE MEDICINE
- Advances in the follow-up of differentiated or medullary thyroid cancer
- (2012) Rossella Elisei et al. Nature Reviews Endocrinology
- Low Prevalence of the Somatic M918T RET Mutation in Micro-Medullary Thyroid Cancer
- (2012) Cristina Romei et al. THYROID
- Evidence of a Low Prevalence of RAS Mutations in a Large Medullary Thyroid Cancer Series
- (2012) Raffaele Ciampi et al. THYROID
- Genetic and Clinical Features of Multiple Endocrine Neoplasia Types 1 and 2
- (2012) C. Romei et al. Journal of Oncology
- In vitro transforming potential, intracellular signaling properties, and sensitivity to a kinase inhibitor (sorafenib) of RET proto-oncogene variants Glu511Lys, Ser649Leu, and Arg886Trp
- (2011) H. Prazeres et al. ENDOCRINE-RELATED CANCER
- In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer
- (2011) B Cosci et al. ENDOCRINE-RELATED CANCER
- Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification
- (2011) Caterina Mian et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- ENDOCRINE TUMOURS: Approach to the patient with advanced differentiated thyroid cancer
- (2011) M Schlumberger et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- High Prevalence ofRASMutations inRET-Negative Sporadic Medullary Thyroid Carcinomas
- (2011) Margarida M. Moura et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Timing of Total Thyroidectomy inRETGene Mutation Carriers Could Be Personalized and Safely Planned on the Basis of Serum Calcitonin: 18 Years Experience at One Single Center
- (2011) Rossella Elisei et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
- (2011) Samuel A. Wells et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeted therapies for thyroid tumors
- (2011) Steven I Sherman MODERN PATHOLOGY
- Predicting Phenotypic Severity of Uncertain Gene Variants in the RET Proto-Oncogene
- (2011) David K. Crockett et al. PLoS One
- Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis
- (2010) Luc G.T. Morris et al. AMERICAN JOURNAL OF SURGERY
- Multiple endocrine neoplasia type 2
- (2010) Nelson Wohllk et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Role of H2O2 in RET/PTC1 Chromosomal Rearrangement Produced by Ionizing Radiation in Human Thyroid Cells
- (2010) R. Ameziane-El-Hassani et al. CANCER RESEARCH
- RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC)
- (2010) C. Romei et al. CLINICAL ENDOCRINOLOGY
- Prevalence of RET/PTC rearrangement in benign and malignant thyroid nodules and its clinical application
- (2010) Anna Guerra et al. ENDOCRINE JOURNAL
- Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes
- (2010) Cristina Romei et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- RET rearrangements and BRAF mutation in undifferentiated thyroid carcinomas having papillary carcinoma components
- (2010) Kunio Mochizuki et al. HISTOPATHOLOGY
- Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10
- (2010) Karin Frank-Raue et al. HUMAN MUTATION
- Impact of Proto-Oncogene Mutation Detection in Cytological Specimens from Thyroid Nodules Improves the Diagnostic Accuracy of Cytology
- (2010) Silvia Cantara et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- DNA breaks at fragile sites generate oncogenic RET/PTC rearrangements in human thyroid cells
- (2010) M Gandhi et al. ONCOGENE
- Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomas
- (2009) M M Moura et al. BRITISH JOURNAL OF CANCER
- Rising Thyroid Cancer Incidence in the United States by Demographic and Tumor Characteristics, 1980-2005
- (2009) L. Enewold et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles for BRAF, PIK3CA, and AKT1
- (2009) J. C. Ricarte-Filho et al. CANCER RESEARCH
- Multiple endocrine neoplasia type 2RETprotooncogene database: Repository of MEN2-associatedRETsequence variation and reference for genotype/phenotype correlations
- (2009) Rebecca L. Margraf et al. HUMAN MUTATION
- RET/PTC Rearrangement Occurring in Primary Peritoneal Carcinoma
- (2009) Richard Flavin et al. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
- Pathogenicity of DNA Variants and Double Mutations in Multiple Endocrine Neoplasia Type 2 and Von Hippel-Lindau Syndrome
- (2009) Zoran Erlic et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Molecular genetics of medullary thyroid carcinoma: the quest for novel therapeutic targets
- (2009) Aniello Cerrato et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Mechanisms of chromosomal rearrangements in solid tumors: The model of papillary thyroid carcinoma
- (2009) Manoj Gandhi et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
- (2009) Richard T. Kloos (Chair) et al. THYROID
- Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
- (2009) David S. Cooper et al. THYROID
- Fine-needle aspiration of the thyroid: today and tomorrow
- (2008) Zubair W. Baloch et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Difference in development of medullary thyroid carcinoma among carriers of RET mutations in codons 790 and 791*
- (2008) Karin Frank-Raue et al. CLINICAL ENDOCRINOLOGY
- BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer
- (2008) C. Romei et al. ENDOCRINE-RELATED CANCER
- Modification of multiple endocrine neoplasia 2A phenotype by cell membrane proximity of RET mutations in exon 10
- (2008) Andreas Machens et al. ENDOCRINE-RELATED CANCER
- RET oncogene in MEN2, MEN2B, MTC and other forms of thyroid cancer
- (2008) Maya B Lodish et al. Expert Review of Anticancer Therapy
- Highly Prevalent Genetic Alterations in Receptor Tyrosine Kinases and Phosphatidylinositol 3-Kinase/Akt and Mitogen-Activated Protein Kinase Pathways in Anaplastic and Follicular Thyroid Cancers
- (2008) Zhi Liu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Prognostic Significance of SomaticRETOncogene Mutations in Sporadic Medullary Thyroid Cancer: A 10-Year Follow-Up Study
- (2007) Rossella Elisei et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started